15/03/2006
A University of Navarra research study on cardiac resynchronization receives an international prizeResearchers from the CIMA and specialists from the University Hospital received the Michel Mirowski Prize during an international congress A research study performed at the University of Navarra on cardiac
resynchronization has received the Michel Mirowski Prize during the
recent international congress on arrhythmias and cardiomyopathies held
in Madrid. The awarding jury, composed by the doctors Hein J.J.
Wellens, Stephan Hohnloser, Arthur Moss and Bernardo Nadal-Ginard,
emphasized “the contribution of this study to knowledge about the
action mechanism of resynchronization therapy in patients with cardiac
insufficiency”.
The authors of the article are researchers in the area of
Cardiovascular Sciences of the CIMA and specialists in the Department
of Cardiology and Cardiovascular Surgery at the University Hospital:
the doctors Ignacio García Bolao, Alfonso Macías, Begoña López, Arantxa
González, Juan José Gavira, Pedro Azcárate, Eduardo Alegría y Javier
Díez. Patients with cardiac insufficiency The discoveries of the study, which was entitled Limitation
of excessive collagen type I synthesis and deposition may contribute to
long-term benefits of cardiac resynchronization therapy in patients
with heart failure, were published in an article which will appears in the June 6th issue of the Journal of the American College of Cardiology.
During the 1970’s and 1980’s, the French cardiologist Michel Mirowski
conceived and developed the first prototypes of implantable automatic
defibrillators for the prevention and treatment of potentially lethal
ventricular arrhythmias. Thanks to his pioneering work, these
mechanisms today form a necessary part of the therapeutic arsenal of
the cardiology and emergency medicine units throughout the world. University Hospital of the University of Navarra
|